TerraPower’s $450M radioisotope factory; Lilly’s $126M Japan budgetnews2026-03-19T17:26:49+00:00March 19th, 2026|Endpoints News|
CSL says its hemophilia B gene therapy is out of stocknews2026-03-19T16:33:06+00:00March 19th, 2026|Endpoints News|
AstraZeneca deepens UK-China ties with cell therapy R&D hub, manufacturing plansnews2026-03-19T15:29:18+00:00March 19th, 2026|Endpoints News|
Lawmakers signal willingness to counter China’s biotech gainsnews2026-03-18T19:41:47+00:00March 18th, 2026|Endpoints News|
Sandoz reorg ahead of ‘golden decade’ for biosimilars; Sanofi to shed Latin America generics businessnews2026-03-12T14:57:02+00:00March 12th, 2026|Endpoints News|
Lilly warns of impurity risk in certain compounded forms of Mounjaro and Zepboundnews2026-03-12T10:53:16+00:00March 12th, 2026|Endpoints News|
Evotec plans up to 800 job cuts, four site closuresnews2026-03-11T19:44:46+00:00March 11th, 2026|Endpoints News|
Lilly plots GLP-1 pill production boost in China, $500M pledge to South Koreanews2026-03-11T15:15:38+00:00March 11th, 2026|Endpoints News|
Incyte receives CRL over issues at Novo’s Indiana factorynews2026-03-09T13:21:57+00:00March 9th, 2026|Endpoints News|
Lonza sells capsule and health ingredients unit for $2.2Bnews2026-03-06T19:50:51+00:00March 6th, 2026|Endpoints News|
